• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于肠道菌群的肾病综合征发病机制探索与中医干预

Exploration of the pathogenesis of nephrotic syndrome and traditional Chinese medicine intervention based on gut microbiota.

作者信息

Li Jing, Xu Yupei, Sun Tianhao, Zhang Xiaotian, Liang Huimin, Lin Wei, Yu Hangxing, Yang Bo, Yang Hongtao

机构信息

Department of Nephrology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.

Department of Nephrology, Traditional Chinese Hospital of Xiamen, Xiamen, China.

出版信息

Front Immunol. 2024 Dec 9;15:1430356. doi: 10.3389/fimmu.2024.1430356. eCollection 2024.

DOI:10.3389/fimmu.2024.1430356
PMID:39717782
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11663840/
Abstract

Nephrotic syndrome (NS) represents a prevalent syndrome among various chronic kidney disease pathologies and is known for its higher severity and worse prognosis compared with chronic glomerulonephritis. Understanding its pathogenesis and identifying more effective treatment modalities have long been a concern of kidney specialists. With the introduction of the gut-kidney axis concept and the progress in omics technologies, alterations in the gut microbiota have been observed in primary and secondary NS. This link has been extensively researched in conditions such as diabetic nephropathy and immunoglobulin A (IgA) nephropathy. Thus, dysbiosis of the gut microbiota is seen as a crucial contributing factor in NS; however, there is a lack of comprehensive reviews that elucidate the changes in the gut microbiota across different NS conditions and that describe its mechanistic role in the disease. Moreover, serving as an innate regulator of the gut microbiota, traditional Chinese medicine (TCM) has the potential to exert a profound impact on the expression of inflammation-promoting agents, decreasing the levels of endotoxins and uremic toxins. In addition, it strengthens the stability of the intestinal barrier while controlling the metabolic function of the body through its efficient modulation of the gut microbiota. This intricate process yields far-reaching consequences for NS.

摘要

肾病综合征(NS)是各种慢性肾脏疾病中常见的综合征,与慢性肾小球肾炎相比,其严重程度更高,预后更差。长期以来,了解其发病机制并确定更有效的治疗方法一直是肾脏专家关注的问题。随着肠-肾轴概念的引入和组学技术的进步,在原发性和继发性NS中均观察到肠道微生物群的改变。这种联系在糖尿病肾病和免疫球蛋白A(IgA)肾病等疾病中已得到广泛研究。因此,肠道微生物群失调被视为NS的一个关键促成因素;然而,缺乏全面的综述来阐明不同NS情况下肠道微生物群的变化及其在疾病中的作用机制。此外,作为肠道微生物群的天然调节剂,中药有可能对促炎因子的表达产生深远影响,降低内毒素和尿毒症毒素水平。此外,它还能增强肠道屏障的稳定性,同时通过有效调节肠道微生物群来控制身体的代谢功能。这一复杂过程对NS产生了深远影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61eb/11663840/f6dc95924262/fimmu-15-1430356-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61eb/11663840/f6dc95924262/fimmu-15-1430356-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61eb/11663840/f6dc95924262/fimmu-15-1430356-g001.jpg

相似文献

1
Exploration of the pathogenesis of nephrotic syndrome and traditional Chinese medicine intervention based on gut microbiota.基于肠道菌群的肾病综合征发病机制探索与中医干预
Front Immunol. 2024 Dec 9;15:1430356. doi: 10.3389/fimmu.2024.1430356. eCollection 2024.
2
Factors affecting dysbiosis of the gut microbiota in the elderly and the progress of interventions in traditional Chinese and Western medicine.影响老年人肠道微生物群失调的因素及中西医干预进展
Front Cell Infect Microbiol. 2025 Mar 24;15:1529347. doi: 10.3389/fcimb.2025.1529347. eCollection 2025.
3
Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota.中医通过靶向肠道微生物群改善糖尿病肾病。
Pharm Biol. 2024 Dec;62(1):423-435. doi: 10.1080/13880209.2024.2351946. Epub 2024 May 17.
4
Compositional alterations of gut microbiota in children with primary nephrotic syndrome after initial therapy.初治后原发性肾病综合征患儿肠道菌群组成改变。
BMC Nephrol. 2019 Nov 26;20(1):434. doi: 10.1186/s12882-019-1615-4.
5
[Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].[慢性肾脏病肠道微生物群失调的发病机制、治疗及中药的干预作用]
Zhongguo Zhong Yao Za Zhi. 2017 Jul;42(13):2425-2432. doi: 10.19540/j.cnki.cjcmm.20170609.014.
6
Microbiota and glomerulonephritis: An immunological point of view.微生物群与肾小球肾炎:免疫学观点。
Am J Med Sci. 2022 Dec;364(6):695-705. doi: 10.1016/j.amjms.2022.05.025. Epub 2022 Jul 20.
7
Gut Microbiota Dysbiosis in Children with Relapsing Idiopathic Nephrotic Syndrome.儿童复发型特发性肾病综合征的肠道菌群失调。
Am J Nephrol. 2018;47(3):164-170. doi: 10.1159/000487557. Epub 2018 Mar 13.
8
Gut microbiota contributes to the distinction between two traditional Chinese medicine syndromes of ulcerative colitis.肠道微生物群有助于溃疡性结肠炎两种中医证候的区分。
World J Gastroenterol. 2019 Jul 7;25(25):3242-3255. doi: 10.3748/wjg.v25.i25.3242.
9
Alterations of gut microbiota and metabolome are associated with primary nephrotic syndrome in children.肠道微生物群和代谢组的改变与儿童原发性肾病综合征有关。
BMC Microbiol. 2024 Dec 5;24(1):519. doi: 10.1186/s12866-024-03667-w.
10
Impact of traditional Chinese medicine treatment on chronic unpredictable mild stress-induced depression-like behaviors: intestinal microbiota and gut microbiome function.中药治疗对慢性不可预测轻度应激诱导的抑郁样行为的影响:肠道微生物群和肠道微生物组功能。
Food Funct. 2019 Sep 1;10(9):5886-5897. doi: 10.1039/c9fo00399a. Epub 2019 Aug 29.

引用本文的文献

1
The role of B lymphocyte subsets in nephrotic syndrome: functions, mechanisms, clinical significance and future perspectives.B淋巴细胞亚群在肾病综合征中的作用:功能、机制、临床意义及未来展望。
Front Immunol. 2025 Aug 7;16:1598197. doi: 10.3389/fimmu.2025.1598197. eCollection 2025.
2
Fecal microbiota transplantation is a promising therapy for kidney diseases.粪便微生物群移植是一种很有前景的肾脏疾病治疗方法。
Front Med (Lausanne). 2025 Jul 9;12:1628722. doi: 10.3389/fmed.2025.1628722. eCollection 2025.
3
Integrated Traditional Chinese and Western Medicine in Lung Adenocarcinoma with Rare EGFR Mutation and Nephrotic Syndrome: A Case Report.

本文引用的文献

1
Corticosteroid therapy for nephrotic syndrome in children.儿童肾病综合征的皮质类固醇治疗。
Cochrane Database Syst Rev. 2024 Aug 22;8(8):CD001533. doi: 10.1002/14651858.CD001533.pub7.
2
Nephrotic Syndrome: From Pathophysiology to Novel Therapeutic Approaches.肾病综合征:从病理生理学到新型治疗方法
Biomedicines. 2024 Mar 3;12(3):569. doi: 10.3390/biomedicines12030569.
3
Efficacy and safety of Mahuang Fuzi and Shenzhuo Decoction for treatment of primary membranous nephropathy: a multicenter prospective trial.麻黄附子细辛汤治疗原发性膜性肾病的疗效及安全性:一项多中心前瞻性试验。
中西医结合治疗罕见表皮生长因子受体突变的肺腺癌合并肾病综合征:一例报告
Cancer Manag Res. 2025 Jul 2;17:1293-1299. doi: 10.2147/CMAR.S526571. eCollection 2025.
Ren Fail. 2024 Dec;46(1):2320834. doi: 10.1080/0886022X.2024.2320834. Epub 2024 Mar 14.
4
Gut microbial metabolites SCFAs and chronic kidney disease.肠道微生物代谢产物 SCFAs 与慢性肾脏病。
J Transl Med. 2024 Feb 18;22(1):172. doi: 10.1186/s12967-024-04974-6.
5
Causal relationship between gut microbiota and kidney diseases: a two-sample Mendelian randomization study.肠道微生物群与肾脏疾病之间的因果关系:两样本孟德尔随机化研究。
Front Immunol. 2024 Jan 12;14:1277554. doi: 10.3389/fimmu.2023.1277554. eCollection 2023.
6
Fangji Huangqi decoction ameliorates membranous nephropathy through the upregulation of BNIP3-mediated mitophagy.防己黄芪汤通过上调BNIP3介导的线粒体自噬改善膜性肾病。
J Ethnopharmacol. 2024 Apr 24;324:117734. doi: 10.1016/j.jep.2024.117734. Epub 2024 Jan 16.
7
Short-chain fatty acids ameliorate experimental anti-glomerular basement membrane disease.短链脂肪酸可改善实验性抗肾小球基底膜病。
Clin Immunol. 2024 Feb;259:109903. doi: 10.1016/j.clim.2024.109903. Epub 2024 Jan 11.
8
The causal association of specific gut microbiota on the risk of membranous nephropathy: a Mendelian randomization study.特定肠道微生物群与膜性肾病风险的因果关联:一项孟德尔随机化研究。
Int Urol Nephrol. 2024 Jun;56(6):2021-2030. doi: 10.1007/s11255-023-03926-1. Epub 2024 Jan 5.
9
Corn silk polysaccharides attenuate diabetic nephropathy through restoration of the gut microbial ecosystem and metabolic homeostasis.玉米须多糖通过恢复肠道微生物生态系统和代谢平衡来减轻糖尿病肾病。
Front Endocrinol (Lausanne). 2023 Dec 4;14:1232132. doi: 10.3389/fendo.2023.1232132. eCollection 2023.
10
Targeted therapies for lupus nephritis: Current perspectives and future directions.狼疮性肾炎的靶向治疗:当前的观点和未来的方向。
Chin Med J (Engl). 2024 Jan 5;137(1):34-43. doi: 10.1097/CM9.0000000000002959. Epub 2023 Dec 7.